55 related articles for article (PubMed ID: 15588345)
1. The density of coreceptors at the surface of CD4+ T cells contributes to the extent of human immunodeficiency virus type 1 viral replication-mediated T cell death.
Lelièvre JD; Petit F; Perrin L; Mammano F; Arnoult D; Ameisen JC; Corbeil J; Gervaix A; Estaquier J
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1230-43. PubMed ID: 15588345
[TBL] [Abstract][Full Text] [Related]
2. R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells.
Cicala C; Arthos J; Martinelli E; Censoplano N; Cruz CC; Chung E; Selig SM; Van Ryk D; Yang J; Jagannatha S; Chun TW; Ren P; Lempicki RA; Fauci AS
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3746-51. PubMed ID: 16505369
[TBL] [Abstract][Full Text] [Related]
3. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
[TBL] [Abstract][Full Text] [Related]
4. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor.
Lee B; Leslie G; Soilleux E; O'Doherty U; Baik S; Levroney E; Flummerfelt K; Swiggard W; Coleman N; Malim M; Doms RW
J Virol; 2001 Dec; 75(24):12028-38. PubMed ID: 11711593
[TBL] [Abstract][Full Text] [Related]
5. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.
Jekle A; Keppler OT; De Clercq E; Schols D; Weinstein M; Goldsmith MA
J Virol; 2003 May; 77(10):5846-54. PubMed ID: 12719578
[TBL] [Abstract][Full Text] [Related]
6. Tree Shrew Cells Transduced with Human CD4 and CCR5 Support Early Steps of HIV-1 Replication, but Viral Infectivity Is Restricted by APOBEC3.
Luo MT; Mu D; Yang X; Luo RH; Zheng HY; Chen M; Guo YQ; Zheng YT
J Virol; 2021 Jul; 95(16):e0002021. PubMed ID: 34076481
[TBL] [Abstract][Full Text] [Related]
7. Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.
Geuenich S; Kaderali L; Allespach I; Sertel S; Keppler OT
J Virol; 2009 Oct; 83(20):10494-503. PubMed ID: 19706709
[TBL] [Abstract][Full Text] [Related]
8. Higher Infectivity of the Human Immunodeficiency Virus in Sensitive Cells with a Modification of the CCR5 Gene.
Nosik DN; Kalnina LB; Selimova LM; Pronin AV
Dokl Biol Sci; 2023 Aug; 511(1):251-254. PubMed ID: 37833581
[TBL] [Abstract][Full Text] [Related]
9. CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.
Olinger GG; Saifuddin M; Spear GT
J Virol; 2000 Sep; 74(18):8550-7. PubMed ID: 10954556
[TBL] [Abstract][Full Text] [Related]
10. Transepithelial transport of HIV-1 by M cells is receptor-mediated.
Fotopoulos G; Harari A; Michetti P; Trono D; Pantaleo G; Kraehenbuhl JP
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9410-4. PubMed ID: 12093918
[TBL] [Abstract][Full Text] [Related]
11. The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells and boosts HIV-1 R5 replication.
Guigues A; Gimenez S; Mettling C; Maurel D; Doumazane E; Prézeau L; François V; Corbeau P
AIDS; 2024 May; ():. PubMed ID: 38770825
[TBL] [Abstract][Full Text] [Related]
12. Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry.
Wojcechowskyj JA; Didigu CA; Lee JY; Parrish NF; Sinha R; Hahn BH; Bushman FD; Jensen ST; Seeholzer SH; Doms RW
Cell Host Microbe; 2013 May; 13(5):613-623. PubMed ID: 23684312
[TBL] [Abstract][Full Text] [Related]
13.
Hoffmann MAG; Kieffer C; Bjorkman PJ
Mol Ther Methods Clin Dev; 2021 Jun; 21():161-170. PubMed ID: 33723514
[TBL] [Abstract][Full Text] [Related]
14. The chemokine receptor CCR5: multi-faceted hook for HIV-1.
Faivre N; Verollet C; Dumas F
Retrovirology; 2024 Jan; 21(1):2. PubMed ID: 38263120
[TBL] [Abstract][Full Text] [Related]
15. CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.
Jasinska AJ; Pandrea I; Apetrei C
Front Immunol; 2022; 13():835994. PubMed ID: 35154162
[TBL] [Abstract][Full Text] [Related]
16. [CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach].
Psomas KC; Corbeau P; Reynes J
Antibiotiques (Paris); 2010 Mar; 12(1):27-41. PubMed ID: 32288525
[TBL] [Abstract][Full Text] [Related]
17. HIV integrase and the swan song of the CD4 T cells?
Estaquier J; Zaunders J; Laforge M
Retrovirology; 2013 Dec; 10():149. PubMed ID: 24321528
[TBL] [Abstract][Full Text] [Related]
18. DRAM triggers lysosomal membrane permeabilization and cell death in CD4(+) T cells infected with HIV.
Laforge M; Limou S; Harper F; Casartelli N; Rodrigues V; Silvestre R; Haloui H; Zagury JF; Senik A; Estaquier J
PLoS Pathog; 2013; 9(5):e1003328. PubMed ID: 23658518
[TBL] [Abstract][Full Text] [Related]
19. Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.
Wright E; Mugaba S; Grant P; Parkes-Ratanshi R; Van der Paal L; Grosskurth H; Kaleebu P
PLoS One; 2011; 6(5):e19902. PubMed ID: 21655330
[TBL] [Abstract][Full Text] [Related]
20. Double-edged genetic swords and immunity: lesson from CCR5 and beyond.
Ahuja SK; He W
J Infect Dis; 2010 Jan; 201(2):171-4. PubMed ID: 20025529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
